In addition, the deletion of Col 1 in α-SMA+ myCAFs leads to CXCL5 upregulation in cancer cells, which is associated with recruitment of MDSCs and suppression of CD8+ T cells, suggesting that myCAFs slow tumour progression in PDAC [101]. Here, CXCL5 is linked to neoplasm.